174 related articles for article (PubMed ID: 21325449)
1. Epidermal growth factor receptor as a biomarker for cervical cancer.
Soonthornthum T; Arias-Pulido H; Joste N; Lomo L; Muller C; Rutledge T; Verschraegen C
Ann Oncol; 2011 Oct; 22(10):2166-78. PubMed ID: 21325449
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer.
Kimmig R; Pfeiffer D; Landsmann H; Hepp H
Int J Cancer; 1997 Aug; 74(4):365-73. PubMed ID: 9291423
[TBL] [Abstract][Full Text] [Related]
4. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
[TBL] [Abstract][Full Text] [Related]
5. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
[TBL] [Abstract][Full Text] [Related]
7. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
Subramanian PD; An Z; Yu JR; Park WY
Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
[TBL] [Abstract][Full Text] [Related]
8. Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
Vaidya AP; Parnes AD; Seiden MV
Curr Treat Options Oncol; 2005 Mar; 6(2):103-14. PubMed ID: 15717992
[TBL] [Abstract][Full Text] [Related]
9. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract][Full Text] [Related]
10. Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
Aydinlik S; Dere E; Ulukaya E
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):903-916. PubMed ID: 30825616
[TBL] [Abstract][Full Text] [Related]
11. Does the epidermal growth factor receptor play a role in the progression of thyroid cancer?
Knauf JA
Thyroid; 2011 Nov; 21(11):1171-4. PubMed ID: 22050034
[No Abstract] [Full Text] [Related]
12. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
Chang HC; Chen YM; Tseng CC; Huang KT; Wang CC; Chen YC; Lai CH; Fang WF; Kao HC; Lin MC
Tumour Biol; 2017 Mar; 39(3):1010428317695939. PubMed ID: 28351317
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-negative colorectal cancer: is there truly such an entity?
Saltz L
Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S98-100. PubMed ID: 16336755
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
15. Detection of epidermal growth factor receptor mRNA in peripheral blood of cervical cancer patients.
Mitsuhashi A; Tanaka N; Suzuka K; Matsui H; Seki K; Sekiya S
Gynecol Oncol; 2003 Jun; 89(3):480-5. PubMed ID: 12798715
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene mutation associated with tyrosine kinase inhibitor sensitivity of epidermal growth factor receptor in cervical cancer patients.
Wei H; Wang XW; Chen KM; Ling SR; Yi CJ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6280-6287. PubMed ID: 30338793
[TBL] [Abstract][Full Text] [Related]
18. Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma.
Kim YT; Park SW; Kim JW
Gynecol Oncol; 2002 Oct; 87(1):84-9. PubMed ID: 12468347
[TBL] [Abstract][Full Text] [Related]
19. Relationship between EGFR over-expression and clinicopathologic characteristics in squamous cell carcinoma of the esophagus: a meta-analysis.
Wang J; Yu JM; Jing SW; Guo Y; Wu YJ; Li N; Jiao WP; Wang L; Zhang YJ
Asian Pac J Cancer Prev; 2014; 15(14):5889-93. PubMed ID: 25081654
[TBL] [Abstract][Full Text] [Related]
20. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
